Abstract | BACKGROUND: METHODS: RESULTS: The pretreatment with GW0742 significantly increased the expression of Bcl-2, and significantly decreased in the volume of infarction, NDS, edema, expressions of IL-1β, NF-κB, TNFα, and Bax, contents of iNOS and the apoptotic cells in infarct cerebral hemisphere compared with rats in the vehicle group at 24 hours after MCAO. CONCLUSIONS:
|
Authors | Xiaodong Chao, Chunlei Xiong, Weifeng Dong, Yan Qu, Weidong Ning, Wei Liu, Feng Han, Yijie Ma, Rencong Wang, Zhou Fei, Hua Han |
Journal | Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
(J Stroke Cerebrovasc Dis)
Vol. 23
Issue 6
Pg. 1396-402
(Jul 2014)
ISSN: 1532-8511 [Electronic] United States |
PMID | 24774438
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Crown Copyright © 2014. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Interleukin-1beta
- NF-kappa B
- PPAR delta
- PPAR-beta
- Thiazoles
- Tumor Necrosis Factor-alpha
- (4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid
|
Topics |
- Animals
- Brain
(drug effects, pathology, physiopathology)
- Brain Ischemia
(drug therapy, pathology, physiopathology)
- Infarction, Middle Cerebral Artery
(drug therapy, pathology, physiopathology)
- Interleukin-1beta
(metabolism)
- Male
- Motor Activity
(drug effects, physiology)
- NF-kappa B
(metabolism)
- PPAR delta
(agonists)
- PPAR-beta
(agonists)
- Rats
- Rats, Sprague-Dawley
- Stroke
(drug therapy, physiopathology)
- Thiazoles
(pharmacology, therapeutic use)
- Tumor Necrosis Factor-alpha
(metabolism)
|